TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 EUR)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
55
|
75
|
69 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-9
|
7
|
1 |
| EBITDA |
-9
|
7
|
1 |
| Total assets |
29
|
47
|
43 |
| Current assets |
29
|
47
|
43 |
| Current liabilities |
9
|
16
|
17 |
| Equity capital |
20
|
31
|
27 |
| - share capital |
8
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
69.0%
|
66.0%
|
62.8% |
| Turnover per employee |
55
|
75
|
69 |
| Profit as a percentage of turnover |
-16.4%
|
9.3%
|
1.4% |
| Return on assets (ROA) |
-31.0%
|
14.9%
|
2.3% |
| Current ratio |
322.2%
|
293.8%
|
252.9% |
| Return on equity (ROE) |
-45.0%
|
22.6%
|
3.7% |
| Change turnover |
-13
|
10
|
-1 |
| Change turnover % |
-19%
|
15%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.